General Information of the Compound
| Compound ID |
CP0055808
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N-methylpropan-1-amine
Show/Hide
|
||||||||||||||||||
| Synonyms |
(3-(10H,11H-Dibenzo[b,f]azepin-5-yl)propyl)methylamine
10, 11-Dihydro-N-methyl-5H-dibez[b,f]azepine-5-propanamine
10,11-Dihydro-5-(3-methylaminopropyl)-5H-dibenz(b,f)azepine
3-(10,11-DIHYDRO-5H-DIBENZO[B,F]AZEPIN-5-YL)-N-METHYLPROPAN-1-AMINE
3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N-methylpropan-1-amine
5-(gamma-Methylaminopropyl)iminodibenzyl
DMI (pharmaceutical)
DMI 50475
Demethylimipramine
Desimipramine
Desimpramine
Desipramin
Desipramina
Desipramina [INN-Spanish]
Desipramine
Desipramine (D4)
Desipramine (INN)
Desipramine Hcl
Desipramine [INN:BAN]
Desipraminum
Desipraminum [INN-Latin]
Desmethylimipramine
Dezipramine
Dimethylimipramine
Methylaminopropyliminodibenzyl
Monodemethylimipramine
N-(3-Methylaminopropyl)iminobibenzyl
Norimipramine
Norpramin (TN)
Norpramine
Pentofran
Pertofrane (TN)
Pertrofane
Sertofran
ZERO/006017
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C18H22N2
|
||||||||||||||||||
| Molecular Weight |
266.388
|
||||||||||||||||||
| Canonical SMILES |
CNCCCN1c2ccccc2CCc2ccccc12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C18H22N2/c1-19-13-6-14-20-17-9-4-2-7-15(17)11-12-16-8-3-5-10-18(16)20/h2-5,7-10,19H,6,11-14H2,1H3
Show/Hide
|
||||||||||||||||||
| InChIKey |
HCYAFALTSJYZDH-UHFFFAOYSA-N
|
||||||||||||||||||
| CAS |
50-47-5
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00825, 5-hydroxytryptamine receptor 2A
Protein ID: PT06109, Geminin
Protein ID: PT01194, Histamine H3 receptor
Protein ID: PT00897, Potassium voltage-gated channel subfamily H member 2
Protein ID: PT01065, Serine/threonine-protein kinase mTOR
Protein ID: PT01105, Sodium channel protein type 5 subunit alpha
Protein ID: PT00884, Sodium-dependent dopamine transporter
Protein ID: PT01026, Sodium-dependent noradrenaline transporter
Cell-based Assay
Protein ID: PT00871, Sodium-dependent serotonin transporter
Protein ID: PT03795, Solute carrier family 22 member 1
Protein ID: PT02031, Voltage-dependent N-type calcium channel subunit alpha-1B
Clinical Information about the Compound